SpringerLink
Log in

Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Esophageal squamous cell carcinoma (ESCC) accounts for the large majority of esophageal cancer cases worldwide. In this review, we examine the potential role of non-acidic fluid (NAF) exposure in ESCC carcinogenesis. Esophageal NAF consists of a mixture of salivary, esophageal, gastric, and duodenal fluids, containing inflammatory constituents such as digestive enzymes and bile acids that induce DNA damage, as well as known carcinogens such as acetaldehyde and N-nitrosamines. Exposure to NAF can occur in the setting of increased non-acid reflux, decreased gastric acidity, and decreased esophageal fluid clearance. Non-acid reflux has been associated with ESCC in small observational studies, and in animal models bile reflux can promote the development of ESCC. Associations have been found between increased ESCC risk and atrophic gastritis, a history of partial gastrectomy, and proton pump inhibitor use, all of which raise the pH of refluxate. Additionally, a minimally or non-acidic gastric environment contains an altered microbiome that can increase the production of acetaldehyde and N-nitrosamines. Esophageal motility disorders such as achalasia and opioid-induced esophageal dysfunction result in increased stasis and exposure to these potentially proinflammatory constituents of NAF. NAF may promote the development of ESCC via multiple mechanisms and is an understudied area of research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015;64:381–387.

    PubMed  Google Scholar 

  2. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 2013;381:400–412.

    PubMed  Google Scholar 

  3. Abnet CC, Arnold M, Wei W-Q. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018;154:360–373.

    PubMed  Google Scholar 

  4. Zikos TA, Clarke JO. Non-acid reflux: when it matters and approach to management. Curr Gastroenterol Rep 2020;22:43.

    PubMed  Google Scholar 

  5. Pandeya N, Olsen CM, Whiteman DC. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol 2013;37:579–584.

    CAS  PubMed  Google Scholar 

  6. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. JNCI J Natl Cancer Instit 2003;95:1404–1413.

    Google Scholar 

  7. Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol 2014;109:822–827.

    PubMed  Google Scholar 

  8. Salaspuro V, Salaspuro M. Synergistic effect of alcohol drinking and smoking onin vivo acetaldehyde concentration in saliva. Int J Cancer 2004;111:480–483.

    CAS  PubMed  Google Scholar 

  9. Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969–2018). In: National Cancer Institute D, Surveillance Research Program, editor.2019.

  10. Brown LM, Hoover R, Silverman D et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001;153:114–122.

    CAS  PubMed  Google Scholar 

  11. Chen Y, Tong Y, Yang C et al. Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. BMC Cancer 2015;15:449.

    PubMed  PubMed Central  Google Scholar 

  12. Sheikh M, Poustchi H, Pourshams A et al. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the golestan cohort study. Gastroenterology 2019;156:1416–1427.

    PubMed  Google Scholar 

  13. Islami F, Ren JS, Taylor PR, Kamangar F. Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. British J Cancer 2009;101:1641–1647.

    CAS  Google Scholar 

  14. Freedman ND, Park Y, Subar AF et al. Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer 2007;121:2753–2760.

    CAS  PubMed  Google Scholar 

  15. Jeurnink SM, Büchner FL, Bueno-De-Mesquita HB et al. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into cancer and nutrition. Int J Cancer 2012;131:E963–E973.

    CAS  PubMed  Google Scholar 

  16. Cai X, Wang C, Yu W et al. Selenium exposure and cancer risk: an updated meta-analysis and meta-regression. Sci Rep 2016;6:19213.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Nasrollahzadeh D, Kamangar F, Aghcheli K et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. British J Cancer 2008;98:1857–1863.

    CAS  Google Scholar 

  18. Sheikh M, Shakeri R, Poustchi H et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Global Health 2020;8:e649–e660.

    PubMed  Google Scholar 

  19. Wen CP, Tsai MK, Chung WSI et al. Cancer risks from betel quid chewing beyond oral cancer: a multiple-site carcinogen when acting with smoking. Cancer Causes Contr 2010;21:1427–1435.

    Google Scholar 

  20. Akhtar S, Sheikh AA, Qureshi HU. Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: A multicentre case–control study. Eur J Cancer 2012;48:655–661.

    PubMed  Google Scholar 

  21. Menya D, Maina SK, Kibosia C et al. Dental fluorosis and oral health in the African esophageal cancer corridor: findings from the Kenya ESCCAPE case–control study and a pan-African perspective. Int J Cancer 2019;145:99–109.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Tran GD, Sun X-D, Abnet CC et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113:456–463.

    CAS  PubMed  Google Scholar 

  23. Okello S, Akello SJ, Dwomoh E et al. Biomass fuel as a risk factor for esophageal squamous cell carcinoma: a systematic review and meta-analysis. Environ Health. 2019;18.

  24. Gammon MD, Schoenberg JB, Ahsan H et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. JNCI J Natl Cancer Instit 1997;89:1277–1284.

    CAS  Google Scholar 

  25. Jansson C. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide swedish case-control study. Cancer Epidemiol Biomarkers Prevent 2005;14:1754–1761.

    Google Scholar 

  26. Dar NA, Shah IA, Bhat GA et al. Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir India. Cancer Sci 2013;104:1231–1236.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Smyth EC, Lagergren J, Fitzgerald RC , et al. Oesophageal cancer. Nature Reviews Disease Primers. 2017;3.

  28. Matejcic M, Gunter MJ, Ferrari P. Alcohol metabolism and oesophageal cancer: a systematic review of the evidence. Carcinogenesis 2017;38:859–872.

    CAS  PubMed  Google Scholar 

  29. Zhao T, Wang C, Shen L et al. Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies. Onco Targets Ther 2015;8:649–659.

    PubMed  PubMed Central  Google Scholar 

  30. Ma K, Cao B, Guo M. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clin Epigenet. 2016;8.

  31. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733–744.

    CAS  PubMed  Google Scholar 

  32. Vakevainen S, Mentula S, Nuutinen H et al. Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol 2002;37:648–655.

    CAS  PubMed  Google Scholar 

  33. Kobayashi J. Effect of diet and gut environment on the gastrointestinal formation of N -nitroso compounds: a review. Nitric Oxide 2018;73:66–73.

    CAS  PubMed  Google Scholar 

  34. Uno K, Iijima K, Hatta W et al. Direct measurement of gastroesophageal reflux episodes in patients with squamous cell carcinoma by 24-h pH-impedance monitoring. Am J Gastroenterol 2011;106:1923–1929.

    CAS  PubMed  Google Scholar 

  35. Kgomo M, Mokoena TR, Ker JA. Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus. BMJ Open Gastroenterol 2017;4:e000180.

    PubMed  PubMed Central  Google Scholar 

  36. Wang SM, Freedman ND, Katki HA et al. Gastroesophageal reflux disease: a risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort. Cancer 2021;127:1871–1879.

    PubMed  Google Scholar 

  37. Pandeya N, Webb PM, Sadeghi S, Green AC, Whiteman DC. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants? Gut 2010;59:31–38.

    CAS  PubMed  Google Scholar 

  38. Lu P, Gu J, Zhang N, Sun Y, Wang J. Risk factors for precancerous lesions of esophageal squamous cell carcinoma in high-risk areas of rural China. Medicine 2020;99:e21426.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–831.

    CAS  PubMed  Google Scholar 

  40. Farrow DC, Vaughan TL, Sweeney C et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Contr 2000;11:231–238.

    CAS  Google Scholar 

  41. Rubio CA, Åberg B. Barrett’s mucosa in conjunction with squamous carcinoma of the esophagus. Cancer 1991;68:583–586.

    CAS  PubMed  Google Scholar 

  42. Shay S, Tutuian R, Sifrim D et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004;99:1037–1043.

    PubMed  Google Scholar 

  43. Tachimori Y, Ozawa S, Numasaki H et al. Comprehensive registry of esophageal cancer in Japan, 2012. Esophagus 2019;16:221–245.

    PubMed  PubMed Central  Google Scholar 

  44. Weusten BL, Akkermans LM, vanBerge-Henegouwen GP, Smout AJ. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol 1994;266:G357-362.

    CAS  PubMed  Google Scholar 

  45. Jenkins GJS, D’Souza FR, Suzen SH et al. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of anti-oxidants in Barrett’s oesophagus. Carcinogenesis 2007;28:136–142.

    CAS  PubMed  Google Scholar 

  46. Miwa K, Sahara H, Segawa M et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996;67:269–274.

    CAS  PubMed  Google Scholar 

  47. Chen KH, Mukaisho K, Ling ZQ, Shimomura A, Sugihara H, Hattori T. Association between duodenal contents reflux and squamous cell carcinoma–establishment of an esophageal cancer cell line derived from the metastatic tumor in a rat reflux model. Anticancer Res 2007;27:175–181.

    PubMed  Google Scholar 

  48. Zhang F, Altorki NK, Wu Y-C, Soslow RA, Subbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391–1399.

    CAS  PubMed  Google Scholar 

  49. **a HHX. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs. Carcinogenesis 2004;26:11–15.

    PubMed  Google Scholar 

  50. Soma T, Kaganoi J, Kawabe A et al. Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: a possible mechanism of angiogenesis in patients with esophageal cancer. Int J Cancer. 2006;119:771–782.

    CAS  PubMed  Google Scholar 

  51. Nishioka K, Doki Y, Miyata H et al. Bile acid promotes the proliferation of squamous cell carcinoma of the esophagus, independent of its inducing COX-2 expression. J Surg Res 2006;132:130–135.

    CAS  PubMed  Google Scholar 

  52. Nieminen M, Salaspuro M. Local Acetaldehyde—an essential role in alcohol-related upper gastrointestinal tract carcinogenesis. Cancers 2018;10:11.

    PubMed Central  Google Scholar 

  53. Nasrollahzadeh D, Malekzadeh R, Ploner A et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep 2015;5:8820.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Stanciu C, Bennett JR. Smoking and gastro-oesophageal reflux. Br Med J 1972;3:793–795.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Kahrilas PJ, Gupta RR. The effect of cigarette smoking on salivation and esophageal acid clearance. J Lab Clin Med 1989;114:431–438.

    CAS  PubMed  Google Scholar 

  56. Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A. The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 1987;258:2077–2079.

    CAS  PubMed  Google Scholar 

  57. Pehl C, Wendl B, Pfeiffer A, Schmidt T, Kaess H. Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci 1993;38:93–96. https://doi.org/10.1007/BF01296779

    Article  CAS  PubMed  Google Scholar 

  58. Pehl C, Pfeiffer A, Wendl B, Kaess H. Different effects of white and red wine on lower esophageal sphincter pressure and gastroesophageal reflux. Scand J Gastroenterol 1998;33:118–122.

    CAS  PubMed  Google Scholar 

  59. Islami F, Sheikhattari P, Ren JS, Kamangar F. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma–a systematic review and meta-analysis. Ann Oncol 2011;22:754–760.

    CAS  PubMed  Google Scholar 

  60. Yokoyama A, Omori T, Yokoyama T et al. Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma. Alcohol Clin Exp Res. 2009;33:898–905.

    CAS  PubMed  Google Scholar 

  61. Kamangar F, Diaw L, Wei W-Q et al. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 2009;124:456–460.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Ren JS, Kamangar F, Qiao YL et al. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 2009;58:636–642.

    CAS  PubMed  Google Scholar 

  63. De Vries AC, Capelle LG, Looman CWN et al. Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: Independent of the severity of atrophic changes. Int J Cancer 2009;124:2135–2138.

    PubMed  Google Scholar 

  64. Tenca A, De Bortoli N, Mauro A et al. Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. Dig Liver Dis 2017;49:978–983.

    CAS  PubMed  Google Scholar 

  65. Oikawa T, Iijima K, Koike T et al. Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria. Scand J Gastroenterol 2010;45:1338–1344.

    CAS  PubMed  Google Scholar 

  66. Roine RP, Salmela KS, Hook-Nikanne J, Kosunen TU, Salaspuro M. Alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori–a possible mechanism behind gastric injury. Life Sci 1992;51:1333–1337.

    CAS  PubMed  Google Scholar 

  67. Netzer P, Gut A, Brundler R, Gaia C, Halter F, Inauen W. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment Pharmacol Therapeut 2001;15:1375–1384.

    CAS  Google Scholar 

  68. Ladas SD, Katsogridakis J, Malamou H, Giannopoulou H, Kesse-Elia M, Raptis SA. Helicobacter pylori may induce bile reflux: link between H pylori and bile induced injury to gastric epithelium. Gut 1996;38:15–18.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Kamangar F, Qiao YL, Blaser MJ et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007;96:172–176.

    CAS  PubMed  Google Scholar 

  70. Xue L, **ng L, Wang J et al. Serum pepsinogens and Helicobacter pylori are not associated with esophageal squamous cell carcinoma in a high-risk area in China. Tumori 2013;99:134–138.

    CAS  PubMed  Google Scholar 

  71. Vohlonen IJ, Hakama M, Harkonen M et al. Oesophageal cancer incidence in 20-year follow-up in a population-based sample of 12 000 middle-age men with or without Helicobacter pylori infection in Finland. Gut 2018;67:1201–1202.

    CAS  PubMed  Google Scholar 

  72. Wu IC, Wu DC, Yu FJ et al. Association between Helicobacter pylori seropositivity and digestive tract cancers. World J Gastroenterol 2009;15:5465–5471.

    PubMed  PubMed Central  Google Scholar 

  73. Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010;139:73–83; quiz e11–72.

  74. Kotilea K, Bontems P, Touati E. Epidemiology, diagnosis and risk factors of helicobacter pylori Infection. Adv Exp Med Biol 2019;1149:17–33.

    CAS  PubMed  Google Scholar 

  75. Brusselaers N, Engstrand L, Lagergren J. Maintenance proton pump inhibition therapy and risk of oesophageal cancer. Cancer Epidemiol 2018;53:172–177.

    PubMed  Google Scholar 

  76. Brusselaers N, Lagergren J, Engstrand L. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer. Cancer Epidemiol 2019;62:101585.

    PubMed  Google Scholar 

  77. Vakevainen S, Tillonen J, Salaspuro M, Jousimies-Somer H, Nuutinen H, Farkkila M. Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol. Aliment Pharmacol Ther 2000;14:1511–1518.

    CAS  PubMed  Google Scholar 

  78. Vaezi MF, Richter JE. Contribution of acid and duodenogastrooesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997;41:297–302.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Yang D, He L, Tong W-H, Jia Z-F, Su T-R, Wang Q. Randomized controlled trial of uncut Roux-en-Y vs Billroth II reconstruction after distal gastrectomy for gastric cancer: which technique is better for avoiding biliary reflux and gastritis? World J Gastroenterol 2017;23:6350.

    PubMed  PubMed Central  Google Scholar 

  80. Kopanski Z, Brandys J, Piekoszewski W, Schlegel-Zawadzka M, Witkowska B. The bacterial flora and the changes of the N-nitrosamine concentration in the operated stomach. Przegl Lek 2001;58:348–350.

    CAS  PubMed  Google Scholar 

  81. Hashimoto N, Inayama M, Fujishima M et al. Esophageal cancer after distal gastrectomy. Dis Esophagus 2006;19:346–349.

    CAS  PubMed  Google Scholar 

  82. Kuwano H, Matsuda H, Nagamatsu M et al. Occurrence of esophageal carcinoma after gastrectomy. J Surg Oncol 1989;41:77–80.

    CAS  PubMed  Google Scholar 

  83. Tachibana M, Abe S, Yoshimura H et al. Squamous cell carcinoma of the esophagus after partial gastrectomy. Dysphagia 1995;10:49–52.

    CAS  PubMed  Google Scholar 

  84. Hsu NY, Chen CY, Chen JT, Hsu CP. Oesophageal squamous cell carcinoma after gastrectomy for benign ulcer disease. Scand J Thorac Cardiovasc Surg 1996;30:29–33.

    CAS  PubMed  Google Scholar 

  85. Thiruvengadam R. Cancer of the nongastric hollow organs of the gastrointestinal tract after gastric surgery. Arch Int Med 1988;148:405.

    CAS  Google Scholar 

  86. Vergouwe FWT, H IJ, Biermann K, et al. High prevalence of barrett's esophagus and esophageal squamous cell carcinoma after repair of Esophageal Atresia. Clin Gastroenterol Hepatol 2018;16:513–521 e516.

  87. Jayasekera CS, Desmond PV, Holmes JA, Kitson M, Taylor AC. Cluster of 4 cases of esophageal squamous cell cancer develo** in adults with surgically corrected esophageal atresia–time for screening to start. J Pediatr Surg 2012;47:646–651.

    PubMed  Google Scholar 

  88. Taylor AC, Breen KJ, Auldist A et al. Gastroesophageal reflux and related pathology in adults who were born with esophageal atresia: a long-term follow-up study. Clin Gastroenterol Hepatol 2007;5:702–706.

    PubMed  Google Scholar 

  89. Chetcuti P, Myers NA, Phelan PD, Beasley SW. Adults who survived repair of congenital oesophageal atresia and tracheo-oesophageal fistula. BMJ. 1988;297:344–346.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Vergouwe FWT, van Wijk MP, Spaander MCW et al. Evaluation of Gastroesophageal Reflux in Children Born With Esophageal Atresia Using pH and Impedance Monitoring. J Pediatr Gastroenterol Nutr 2019;69:515–522.

    PubMed  PubMed Central  Google Scholar 

  91. Tustumi F, Bernardo WM, da Rocha JRM, et al. Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis. Dis Esophagus 2017;30:1–8.

  92. Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur J Gastroenterol Hepatol 2008;20:956–960.

    PubMed  Google Scholar 

  93. Fisichella PM, Raz D, Palazzo F, Niponmick I, Patti MG. Clinical, radiological, and manometric profile in 145 patients with untreated Achalasia. World J Surg 2008;32:1974–1979.

    PubMed  Google Scholar 

  94. Kim H, Park H, Choi H et al. Retention Esophagitis as a significant clinical predictor of progression to esophageal cancer in Achalasia. Clin Endosc 2018;51:161–166.

    PubMed  PubMed Central  Google Scholar 

  95. Lehman MB, Clark SB, Ormsby AH, Rice TW, Richter JE, Goldblum JR. Squamous mucosal alterations in esophagectomy specimens from patients with end-stage achalasia. Am J Surg Pathol 2001;25:1413–1418.

    CAS  PubMed  Google Scholar 

  96. Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18:327–337.

    CAS  PubMed  Google Scholar 

  97. Chino O, Kijima H, Shimada H et al. Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures. Anticancer Res 2000;20:3717–3722.

    CAS  PubMed  Google Scholar 

  98. Patel D, Callaway J, Vaezi M. Opioid-induced foregut dysfunction. Am J Gastroenterol 2019;114:1716–1725.

    PubMed  Google Scholar 

  99. Babaei A, Szabo A, Shad S, Massey BT. Chronic daily opioid exposure is associated with dysphagia, esophageal outflow obstruction, and disordered peristalsis. Neurogastroenterol Motil. 2019;31:e13601.

    PubMed  PubMed Central  Google Scholar 

  100. Gomez Cifuentes JD, Thota PN, Lopez R. Lower prevalence of gastroesophageal reflux disease in patients with noncardiac chest pain on opiates: a cross-sectional study. Diseases of the Esophagus. 2018;31.

  101. Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol 2019;114:1464–1469.

    PubMed  Google Scholar 

  102. Etemadi A, Poustchi H, Calafat AM et al. Opiate and tobacco use and exposure to carcinogens and toxicants in the golestan cohort study. Cancer Epidemiol Biomark Prevent 2020;29:650–658.

    CAS  Google Scholar 

  103. Kalant H. Opium revisited: a brief review of its nature, composition, non-medical use and relative risks. Addiction 1997;92:267–277.

    CAS  PubMed  Google Scholar 

  104. Courbette O, Omari T, Aspirot A, Faure C. Characterization of esophageal motility in children with operated esophageal atresia using high-resolution impedance manometry and pressure flow analysis. J Pediatr Gastroenterol Nutr 2020;71:304–309.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was not supported by any grant funding.

Author information

Authors and Affiliations

  1. Department of Medicine, Columbia University Irving Medical Center, 630 W 168th Street, P&S 3-401, New York, NY, 10032, USA

    Ali Soroush & Julian A. Abrams

  2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 630 W 168th Street, P&S 3-401, Bethesda, MD, USA

    Arash Etemadi

Authors
  1. Ali Soroush
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arash Etemadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julian A. Abrams
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Soroush.

Ethics declarations

Conflict of interest

The authors declare no potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soroush, A., Etemadi, A. & Abrams, J.A. Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma. Dig Dis Sci 67, 2754–2762 (2022). https://doi.org/10.1007/s10620-021-07127-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-021-07127-7

Keywords

Search

Navigation